Literature DB >> 12477929

Genetic variation in the 22q11 locus and susceptibility to schizophrenia.

Hui Liu1, Goncalo R Abecasis, Simon C Heath, Alyson Knowles, Sandra Demars, Ying-Jiun Chen, J Louw Roos, Judith L Rapoport, Joseph A Gogos, Maria Karayiorgou.   

Abstract

An increased prevalence of microdeletions at the 22q11 locus has been reported in samples of patients with schizophrenia. 22q11 microdeletions represent the highest known genetic risk factor for the development of schizophrenia, second only to that of the monozygotic cotwin of an affected individual or the offspring of two schizophrenic parents. It is therefore clear that a schizophrenia susceptibility locus maps to chromosome 22q11. In light of evidence for suggestive linkage for schizophrenia in this region, we hypothesized that, whereas deletions of chromosome 22q11 may account for only a small proportion of schizophrenia cases in the general population (up to approximately 2%), nondeletion variants of individual genes within the 22q11 region may make a larger contribution to susceptibility to schizophrenia in the wider population. By studying a dense collection of markers (average one single nucleotide polymorphism20 kb over 1.5 Mb) in the vicinity of the 22q11 locus, in both family- and population-based samples, we present here results consistent with this assumption. Moreover, our results are consistent with contribution from more than one gene to the strikingly increased disease risk associated with this locus. Finer-scale haplotype mapping has identified two subregions within the 1.5-Mb locus that are likely to harbor candidate schizophrenia susceptibility genes.

Entities:  

Mesh:

Year:  2002        PMID: 12477929      PMCID: PMC139234          DOI: 10.1073/pnas.232186099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

Authors:  T Nagase; K Ishikawa; R Kikuno; M Hirosawa; N Nomura; O Ohara
Journal:  DNA Res       Date:  1999-10-29       Impact factor: 4.458

2.  Circumventing multiple testing: a multilocus Monte Carlo approach to testing for association.

Authors:  L M McIntyre; E R Martin; K L Simonsen; N L Kaplan
Journal:  Genet Epidemiol       Date:  2000-07       Impact factor: 2.135

3.  A general test of association for quantitative traits in nuclear families.

Authors:  G R Abecasis; L R Cardon; W O Cookson
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

4.  Velocardiofacial syndrome in childhood-onset schizophrenia.

Authors:  S I Usiskin; R Nicolson; D M Krasnewich; W Yan; M Lenane; M Wudarsky; S D Hamburger; J L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-12       Impact factor: 8.829

5.  The DHHC domain: a new highly conserved cysteine-rich motif.

Authors:  T Putilina; P Wong; S Gentleman
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

6.  High rates of schizophrenia in adults with velo-cardio-facial syndrome.

Authors:  K C Murphy; L A Jones; M J Owen
Journal:  Arch Gen Psychiatry       Date:  1999-10

7.  Erf2, a novel gene product that affects the localization and palmitoylation of Ras2 in Saccharomyces cerevisiae.

Authors:  D J Bartels; D A Mitchell; X Dong; R J Deschenes
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

8.  A common molecular basis for rearrangement disorders on chromosome 22q11.

Authors:  L Edelmann; R K Pandita; E Spiteri; B Funke; R Goldberg; N Palanisamy; R S Chaganti; E Magenis; R J Shprintzen; B E Morrow
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

9.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice.

Authors:  J A Gogos; M Santha; Z Takacs; K D Beck; V Luine; L R Lucas; J V Nadler; M Karayiorgou
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

10.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis.

Authors:  T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

View more
  65 in total

1.  Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice.

Authors:  Anatole Ghazalpour; Xuping Wang; Aldons J Lusis; Margarete Mehrabian
Journal:  Genetics       Date:  2006-04-19       Impact factor: 4.562

Review 2.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 3.  Bipolar disorder and schizophrenia: convergent molecular data.

Authors:  Wade Berrettini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 4.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

5.  Loss of microRNAs in pyramidal neurons leads to specific changes in inhibitory synaptic transmission in the prefrontal cortex.

Authors:  Ruby Hsu; Claude M Schofield; Cassandra G Dela Cruz; Dorothy M Jones-Davis; Robert Blelloch; Erik M Ullian
Journal:  Mol Cell Neurosci       Date:  2012-06-20       Impact factor: 4.314

6.  Lower prepulse inhibition in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Maria Karayiorgou
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

7.  White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis.

Authors:  Matthew D Perlstein; Moeed R Chohan; Ioana L Coman; Kevin M Antshel; Wanda P Fremont; Matthew H Gnirke; Zora Kikinis; Frank A Middleton; Petya D Radoeva; Martha E Shenton; Wendy R Kates
Journal:  Schizophr Res       Date:  2013-12-08       Impact factor: 4.939

Review 8.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

9.  Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen.

Authors:  Debora Bogani; Catherine Willoughby; Jennifer Davies; Kulvinder Kaur; Ghazala Mirza; Anju Paudyal; Heather Haines; Richard McKeone; Matthew Cadman; Guido Pieles; Jürgen E Schneider; Shoumo Bhattacharya; Andrea Hardy; Patrick M Nolan; Nikos Tripodis; Michael J Depew; Ramya Chandrasekara; Gimara Duncan; Paul T Sharpe; Andy Greenfield; Paul Denny; Steve D M Brown; Jiannis Ragoussis; Ruth M Arkell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

10.  A conserved active site tyrosine residue of proline dehydrogenase helps enforce the preference for proline over hydroxyproline as the substrate.

Authors:  Elizabeth L Ostrander; John D Larson; Jonathan P Schuermann; John J Tanner
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.